<DOC>
	<DOCNO>NCT00761436</DOCNO>
	<brief_summary>Tolerability Efficacy Spheramine evaluate operative implantation ( Stereotactic Intrastriatal Implantation ) patient advance Parkinson 's Disease</brief_summary>
	<brief_title>Pilot Study Safety Efficacy Spheramine</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease ( PD ) . As defined : presence bradykinesia either rest tremor rigidity history asymmetry PD sign history progression PD sign , suspect cause PD sign Patient 40 70 year age , inclusive Patient Ldopasensitive unequivocal clinical `` '' period document home diary , complete 4 consecutive day average 1.5 hours/day clinically `` '' state Patient Hoehn &amp; Yahr stage III high practically define `` '' phase All medical problem stable control contraindication general anesthesia stereotactic neurosurgery Patient 's brain magnetic imaging resonance ( MRI ) show abnormality would contraindicate Spheramine implantation Patient major psychiatric problem dementia Patient must give write informed consent participate study Patient must stable dose antiparkinsonian medication least 1 month prior completion home diary assessment baseline UPDRS assessment If patient woman childbearing potential , must nurse pregnant must use adequate form birth control duration study deem appropriate investigator oral contraceptive , IUD , condoms Patient must live close constant contact person contribute information patient 's condition implant provide assistance , necessary Patients atypical Parkinson 's disease ( e.g . parkinsonian `` plus '' syndrome , secondary Parkinsonian syndrome ) Patients exhibit tremorbased symptomatology Patients exhibit severe dyskinesia ( last 2 hour/day ) exacerbate Ldopa , evaluate 4/4 dyskinesia scale ( violent dyskinesia , incompatible normal motor task ) Women childbearing potential without contraception Patients noncooperative incapable complete selfevaluation scale diaries Patients present know pharmacologic immunosuppression relate chemotherapeutic treatment malignancy , autoimmune disease , allografts medical condition associate immunosuppression Patient 's cardiovascular , pulmonary , renal hematological state contraindicates use general anesthesia Evidence abnormal coagulation include PT &gt; 13 sec , PT &gt; 35 sec platelet &lt; 5 ml Patients previous stereotactic brain surgery Patients treat apomorphine pump Patients significant cognitive impairment , untreated treatment resistant depression , psychosis , hallucination delusion would prevent effective participation study Patients participate another experimental drug device trial past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>